Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy ; volume:22 ; number:1 ; day:3 ; month:7 ; year:2021 ; pages:1-9 ; date:12.2021
BMC immunology ; 22, Heft 1 (3.7.2021), 1-9, 12.2021
- Creator
-
Ghaffari, Sasan
Torabi-Rahvar, Monireh
Aghayan, Sajjad
Jabbarpour, Zahra
Moradzadeh, Kobra
Omidkhoda, Azadeh
Ahmadbeigi, Naser
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12865-021-00435-7
- URN
-
urn:nbn:de:101:1-2021101322034382866103
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ghaffari, Sasan
- Torabi-Rahvar, Monireh
- Aghayan, Sajjad
- Jabbarpour, Zahra
- Moradzadeh, Kobra
- Omidkhoda, Azadeh
- Ahmadbeigi, Naser
- SpringerLink (Online service)
Other Objects (12)
Adoptive T-cell therapy for Leukemia
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
Genetically-engineered T cells for adoptive T-cell therapy : from CARs to TRUCKs and beyond
Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy
A modified P450 Cytochrome as Safety Mechanism in Adoptive T-cell Therapy
High-intensity interval training in allogeneic adoptive T-cell immunotherapy – a big HIT?
The effect of endurance exercise on virus-specific cytotoxic T-cells for allogeneic adoptive T-cell immunotherapy
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy
ARHGAP45 controls naïve T‐ and B‐ cell entry into lymph nodes and T‐cell progenitor thymus seeding
Adoptive T-cell therapy for Leukemia
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
Genetically-engineered T cells for adoptive T-cell therapy : from CARs to TRUCKs and beyond
Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy
A modified P450 Cytochrome as Safety Mechanism in Adoptive T-cell Therapy
High-intensity interval training in allogeneic adoptive T-cell immunotherapy – a big HIT?
The effect of endurance exercise on virus-specific cytotoxic T-cells for allogeneic adoptive T-cell immunotherapy
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy
ARHGAP45 controls naïve T‐ and B‐ cell entry into lymph nodes and T‐cell progenitor thymus seeding
Adoptive T-cell therapy for Leukemia
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
Genetically-engineered T cells for adoptive T-cell therapy : from CARs to TRUCKs and beyond
Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy
A modified P450 Cytochrome as Safety Mechanism in Adoptive T-cell Therapy
High-intensity interval training in allogeneic adoptive T-cell immunotherapy – a big HIT?
The effect of endurance exercise on virus-specific cytotoxic T-cells for allogeneic adoptive T-cell immunotherapy
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy